GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » 12-1 Month Momentum %

Livzon Pharmaceutical Group (SZSE:000513) 12-1 Month Momentum % : N/A% (As of May. 12, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-12), Livzon Pharmaceutical Group's 12-1 Month Momentum % is N/A%.

The industry rank for Livzon Pharmaceutical Group's 12-1 Month Momentum % or its related term are showing as below:

SZSE:000513's 12-1 Month Momentum % is not ranked *
in the Drug Manufacturers industry.
Industry Median: -6.39
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Livzon Pharmaceutical Group's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's 12-1 Month Momentum % falls into.



Livzon Pharmaceutical Group  (SZSE:000513) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Livzon Pharmaceutical Group  (SZSE:000513) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Livzon Pharmaceutical Group 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines